New York State Common Retirement Fund’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

New York State Common Retirement Fund’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,600	Closed	-$14K	–	3316
2018 Q1	$14K	Hold	9,600	–	–	﹤0.01%	3071
2017 Q4	$22K	Hold	9,600	–	–	﹤0.01%	3070
2017 Q3	$33K	Hold	9,600	–	–	﹤0.01%	3077
2017 Q2	$34K	Sell	9,600 -1	-0%	-$3	﹤0.01%	3162
2017 Q1	$33K	Buy	9,601 +1	+0%	+$4	﹤0.01%	3097
2016 Q4	$44K	Hold	9,600	–	–	﹤0.01%	3078
2016 Q3	$41K	Hold	9,600	–	–	﹤0.01%	3093
2016 Q2	$23K	Hold	9,600	–	–	﹤0.01%	3135
2016 Q1	$45K	Hold	9,600	–	–	﹤0.01%	3080
2015 Q4	$38K	Hold	9,600	–	–	﹤0.01%	3131
2015 Q3	$37K	Buy	9,600 +2,660	+38%	+$12.2K	﹤0.01%	3136
2015 Q2	$32K	Buy	+6,940	New	+$66.5K	﹤0.01%	3250

Other funds holding AST

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

New York State Common Retirement Fund's AST Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q2 2018, closing a stake of 9,600 shares — an estimated $14K sold.

New York State Common Retirement Fund first reported a position in AST in Q2 2015 and held it in 12 quarters. The position peaked at $45K in Q1 2016. 62 funds tracked by Wall St. Rank hold AST as of Q2 2018.

New York State Common Retirement Fund reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q2 2018 after selling out during the quarter.
New York State Common Retirement Fund sold 9,600 Asterias Biotherapeutics Inc. Series A shares in Q2 2018, an estimated $14K.
New York State Common Retirement Fund first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 12 quarters.
New York State Common Retirement Fund's Asterias Biotherapeutics Inc. Series A position peaked at $45K in Q1 2016.
62 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.